Nocturia and overnight polysomnography in Parkinson disease

Neurourology and Urodynamics

Volumn 32, Issue 8, 2013, Pages 1080-1085

  Vaughan, Camille P ^a,b   Juncos, Jorge L ^b   Trotti, Lynn Marie ^b   Johnson II, Theodore M ^a,b   Bliwise, Donald L ^b,c  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

bother; nocturia; Parkinson disease; polysomnography; sleep efficiency

Indexed keywords

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; CLINICAL ASSESSMENT; FEMALE; HOSPITAL PATIENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; QUALITY OF LIFE; SECONDARY ANALYSIS; SLEEP; SLEEP QUALITY; SLEEP TIME; URINARY FREQUENCY;

BOTHER; NOCTURIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; SLEEP EFFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NOCTURIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; QUALITY OF LIFE; SLEEP;

EID: 84886418352     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22365     Document Type: Article

References (25)

1. Gallagher DA, Lees AJ, Schrag A,. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them ? Mov Disord 2010; 25: 2493-500.
2. Winge K, Skau A-M, Stimpel H, et al. Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 2006; 25: 116-22.
3. Martinez-Martin P, Schapira AHV, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623-29.
4. Coyne KS, Zhou Z, Bhattacharyya SK, et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003; 92: 948-54.
5. Tikkinen KA, Johnson TM II, Tammela TL, et al. Nocturia frequency, bother, and quality of life: How often is too often? A population-based study in Finland. Euro Urol 2010; 57: 488-96.
6. Yoshimura K, Kamoto T, Oka Y, et al. Differences between bothersome and non-bothersome night-time frequency. Neurourol Urodyn 2007; 26: 1014-19.
7. Yu H-J, Chen F-Y, Huang P-C, et al. Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology 2006; 67: 713-18.
8. Endeshaw Y,. Correlates of self-reported nocturia among community-dwelling older adults. J Gerontol Ser A Biol Sci Med Sci 2009; 64A: 142-48.
9. Vaughan CP, Eisenstein R, Bliwise D, et al. Self-rated sleep characteristics and bother from nocturia. Int J Clin Pract 2012; 66: 369-73.
10. Parthasarathy S, Fitzgerald M, Goodwin JL, et al. Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort. PLoS ONE 2012; 7: e30969.
11. Bliwise DL, Trotti LM, Wilson AG, et al. Daytime alertness in Parkinson's disease: Potentially dose-dependent, divergent effects by drug class. Mov Disord 2012; 27: 1118-24.
12. Bliwise DL, Williams ML, Irbe D, et al. Inter-rater reliability for identification of REM sleep in Parkinson's disease. Sleep 2000; 23: 671-76.
13. van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardisation of terminology in nocturia: Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 179-83.
14. Agnew HW, Webb WB, Williams RL,. The first night effect: An EEG study of sleep. Psychophysiology 1966; 2: 263-66.
15. Barry MJ, Fowler FJ, Jr., O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57.
16. O'Leary MP,. Validity of the "Bother Score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia. Rev Urol 2005; 7: 1-10.
17. Hobson DE, Lang AE, Martin WRW, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. JAMA 2002; 287: 455-63.
18. Grosset KA, Grosset DG,. Proposed dose equivalence for rapid switching between dopamine agonists in Parkinson's disease. Clin Therapeut 2006; 28: 1063-64.
19. Folstein MF, Folstein SE, McHugh PR,. " Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975; 12: 189-98.
20. Bliwise DL, Trotti LM, Rye DB,. Movement disorders specific to sleep and sleep in waking movement disorders. In:, Watts RL, Standaert DG, Obeso JA, editors. Movement disorders. New York: McGraw Hill; 2012. pp. 935-74.
21. Endeshaw YW, Johnson TM, Kutner MH, et al. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc 2004; 52: 957-60.
22. Cochen De Cock V, Abouda M, Leu S, et al. Is obstructive sleep apnea a problem in Parkinson's disease ? Sleep Med 2010; 11: 247-52.
23. Young A, Horne M, Churchward T, et al. Comparison of sleep disturbance in mild versus severe Parkinson's disease. Sleep 2002; 25: 573-77.
24. Dhawan V, Dhoat S, Williams AJ, et al. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. J Neurol Sci 2006; 248: 158-62.
25. Schrag A, Sampaio C, Counsell N, et al. Minimal clinically important change on the unified Parkinson's disease rating scale. Mov Disord 2006; 21: 1200-07. Stroke